Abstract
NEW YORK Medtech startup Presymptom Health said Thursday that it has secured £200,000 ($253,000) in grant funding that will support the development and commercialization in the UK of its rapid testing platform for sepsis and infectious disease.
Key Data
-
Publication Date27 February 2025
-
Primary Author360Dx
-
Source360Dx
-
LanguageEnglish
Click below to visit original source: